These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37183588)

  • 1. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
    Bouchi R; Sugiyama T; Goto A; Ohsugi M; Yoshioka N; Katagiri H; Mita T; Hirota Y; Ikegami H; Matsuhisa M; Araki E; Yokoyama H; Minami M; Yamazaki K; Jinnouchi H; Ikeda H; Fujii H; Nogawa M; Kaneshige M; Miyo K; Ueki K
    J Diabetes Investig; 2023 Aug; 14(8):994-1004. PubMed ID: 37183588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.
    Terakawa A; Bouchi R; Kodani N; Hisatake T; Sugiyama T; Matsumoto M; Ihana-Sugiyama N; Ohsugi M; Ueki K; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1094-1104. PubMed ID: 35088564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Benefit of Teleconsultation for Diabetes Management During the COVID-19 Pandemic: A French Observational Prospective Study.
    Meyer L; Flocard M; Fabacher T; Bahougne T; Ortéga F; Paris D; Munch M; Boullu-Sanchis S; Canel C; Chappaz C; Amoura L; Meyer N; Kessler L
    Telemed J E Health; 2023 Apr; 29(4):612-616. PubMed ID: 35944265
    [No Abstract]   [Full Text] [Related]  

  • 4. Substitution of telemedicine for clinic visit during the COVID-19 pandemic of 2020: Comparison of telemedicine and clinic visit.
    Onishi Y; Ichihashi R; Yoshida Y; Tahara T; Kikuchi T; Kobori T; Kubota T; Iwamoto M; Hamano S; Kasuga M
    J Diabetes Investig; 2022 Sep; 13(9):1617-1625. PubMed ID: 35524476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.
    Sankoda A; Nagae Y; Waki K; Sze WT; Oba K; Mieno M; Nangaku M; Yamauchi T; Ohe K
    JMIR Diabetes; 2023 Nov; 8():e42607. PubMed ID: 37315193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: A retrospective longitudinal observational study.
    Sawada M; Ohkuma K; Aihara M; Doi S; Sekine R; Kaneko T; Iimuro S; Ichi I; Usami S; Ohe K; Yamauchi T; Kubota N
    J Diabetes Investig; 2023 Feb; 14(2):321-328. PubMed ID: 36346131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.
    Takahara M; Watanabe H; Shiraiwa T; Maeno Y; Yamamoto K; Shiraiwa Y; Yoshida Y; Nishioka N; Katakami N; Shimomura I
    J Diabetes Investig; 2022 Feb; 13(2):375-385. PubMed ID: 33768726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Person and Telehealth Provider Access and Glycemic Control for People With Diabetes During the COVID-19 Pandemic.
    Eiland L; Datta P; Samson K; Anzalone J; Donovan A; McAdam-Marx C
    J Diabetes Sci Technol; 2023 Jul; 17(4):895-900. PubMed ID: 36999204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
    Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
    Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
    Onishi Y; Yoshida Y; Takao T; Tahara T; Kikuchi T; Kobori T; Kubota T; Shimmei A; Iwamoto M; Kasuga M
    J Diabetes Investig; 2022 Feb; 13(2):386-390. PubMed ID: 33728760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Covid-19 on Diabetes Care in Muscat Governorate: A Retrospective Cohort Study in Primary Care.
    Al Harthi T; Anwar H; Al Lawati A; Al Shuriqi F; Al Rashdi F; Al Mahrouqi A; Al Ismaili M; Al Syiabi R; Al Azri H; Meah UH; Al Ghafri T
    J Prim Care Community Health; 2021; 12():21501327211051930. PubMed ID: 34719302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Pharmacist-Led Telemedicine on A1c Reduction During the COVID-19 Pandemic.
    Ahmed F; Hammad S; Redmann O; Smith C; Edwards C; Kader C; Hammoudeh D; Zeidan R
    Telemed J E Health; 2024 Jan; 30(1):166-172. PubMed ID: 37294586
    [No Abstract]   [Full Text] [Related]  

  • 14. The Impact of Telemedicine-Augmented Integrated Personalized Diabetes Management on Glycemic Control in Adults With Diabetes Mellitus During the COVID-19 Pandemic: A Retrospective Study.
    Greeviroj P; Thavaraputta S; Buranasupkajorn P; Laichuthai N
    Asia Pac J Public Health; 2023 Mar; 35(2-3):194-196. PubMed ID: 36840347
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between telemedicine use and diabetes risk factor assessment and control in a primary care network.
    Grauer A; Duran AT; Liyanage-Don NA; Torres-Deas LM; Metser G; Moise N; Kronish IM; Ye S
    J Endocrinol Invest; 2022 Sep; 45(9):1749-1756. PubMed ID: 35596919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telemedicine for the Underserved Racial and Ethnic Minorities During COVID-19 and Beyond.
    Sarwal A; Lim J; Sarwal A
    Telemed J E Health; 2024 Jun; 30(6):1588-1593. PubMed ID: 38739446
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of gender differences on lifestyle and glycemic control in Japanese patients with diabetes during COVID-19 lockdowns.
    Shikuma J; Nagai Y; Sakurai M; Udagawa K; Ito R; Miwa T; Suzuki R
    Prim Care Diabetes; 2022 Jun; 16(3):350-354. PubMed ID: 35283067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic.
    Chobot A; Lanzinger S; Alkandari H; Todd Alonso G; Blauensteiner N; Coles N; De Sanctis L; Mul D; Saboo B; Smart C; Tsai MC; Zabeen B; Dovc K
    Diabetes Res Clin Pract; 2023 Aug; 202():110809. PubMed ID: 37385473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscany.
    Bellini B; Nreu B; Francesconi P; Mannucci E
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2588-2593. PubMed ID: 36064691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
    Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H
    Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.